Literature DB >> 23610149

Intracranial extramedullary hematopoiesis associated with multiple myeloma.

Jose-Alberto Palma1, Pablo D Dominguez, Mario Riverol.   

Abstract

A 77-year-old woman with multiple myeloma for 5 years presented with obtundation, drowsiness, and disorientation over 15 days. Complete blood count revealed thrombocytopenia (25,000/µL). A brain CT disclosed multiple extraaxial hyperdense foci without bone destruction. Differential diagnosis included tumors (meningiomas, leukemia), subdural hematomas, and intracranial hemorrhages; the lesion's multiplicity and morphology were consistent with intracranial extramedullary hematopoiesis (IEH) (figure). Despite platelet transfusions, she died 2 days later of alveolar hemorrhage. Autopsy confirmed IEH and excluded erythropoiesis, reported in subdural hematomas. The formation of blood cells outside the bone marrow is usually related to anemia or lymphoproliferative disorders and is uncommon in multiple myeloma.(1) IEH can cause seizures, hydrocephalus, or cognitive changes.(2.)

Entities:  

Mesh:

Year:  2013        PMID: 23610149     DOI: 10.1212/WNL.0b013e31828f1899

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  2 in total

1.  Juvenile myelomonocytic leukemia presenting in an infant with a subdural hematoma.

Authors:  William A Lambert; Joseph A DiGiuseppe; Tatiana Lara-Ospina; Markus J Bookland; Jonathan E Martin; David S Hersh
Journal:  Childs Nerv Syst       Date:  2021-01-06       Impact factor: 1.475

2.  Lack of Spleen Signal on Diffusion Weighted MRI is associated with High Tumor Burden and Poor Prognosis in Multiple Myeloma: A Link to Extramedullary Hematopoiesis?

Authors:  Leo Rasche; Manoj Kumar; Grant Gershner; Rohan Samant; Rudy Van Hemert; Anke Heidemeier; Constantin Lapa; Thorsten Bley; Andreas Buck; James McDonald; Jens Hillengass; Joshua Epstein; Sharmilan Thanendrarajan; Carolina Schinke; Frits van Rhee; Maurizio Zangari; Bart Barlogie; Faith E Davies; Gareth J Morgan; Niels Weinhold
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.